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The treatment of diluted solutions of the hydroxydiamides 6a and 6b in toluene with HCl gas 
at 100o gave the dimeric, 14-membered cyclodepsipeptide 10 in up to 72% yield (Scheme 3). 
The same product was formed from the linear dimer of 6b, the depsipeptide 11, under the 
same conditions (Scheme 4). All attempts to prepare the cyclic 7-membered monomer 9, 
starting with different precursors and using different lactonization methods failed, and 10 was 
the only product which was formed (Scheme 6). For example, the reaction of the ester 20 with 
NaH in toluene at 80o led exclusively to the cyclodimer 10. On the other hand, the base 
catalyzed cyclization of the hydroxydiester 22, which is the ‘O-analogue’ of 20, yielded 
neither the 7-membered dilactone, nor the 14-membered tetralactone, but only the known 
trimer  23 and tetramer 24 of 2,2-dimethylpropiolactone (Scheme 7). 
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1. Introduction  
The continuous and current interest in cyclic depsipeptides is a result of their well known  
biological activity. A large number of them have been isolated from natural sources, mainly 
from marine or surface cultures of the corresponding microorganisms (cf. [1-8]). Typical 
examples are the antibiotics valinomycin [9-11] and the enniatins [12], which act as 
ionophores [13]. The most demanding step in the synthesis of such compounds is the 
cyclization. As they contain amide groups and at least one ester group in the core, the cyclic 
depsipeptides could be prepared by the formation of either the amide or ester bonds as the 
ring closure step.  
 
The cyclization via amide-bond formation (lactamization; e.g. [14-16]) is usually carried out 
by following protocols for the synthesis of cyclopeptides using coupling reagents. On the 
other hand, successful cyclizations via ester-bond formation (lactonization; e.g. [17-19]) have 
also been described. In the last few years, the number of reports on the use of 
macrolactonizations in the preparation of cyclodepsipeptides has increased remarkably [6-
8][20][21]. A useful method for the ring closure of depsipeptides which contain 
α,α−disubstituted α−amino acids is the so-called ‘direct amide cyclization’ method, 
developed in our laboratory [22-28]. The basic concept is that an amide of type 1 in a toluene 
solution or suspension is treated with dry HCl gas. Cyclization by elimination of the 
corresponding  ammonium chloride leads to the intermediate 1,3-oxazol-5(4H)-one of type 2. 
In the absence of other nucleophiles, the oxazolone undergoes a ring enlargement via 
intramolecular nucleophilic attack of the hydroxyl group at the carbonyl C-atom of the 
neighboring lactone group, leading to the depsipeptide 3 (Scheme 1). 
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Scheme 1 
 
 
 
As was reported earlier, this method has been used efficiently for the synthesis of morpholine-
2,5-diones (i.e. 6-membered cyclic depsipeptides)
 
[23][29] as well as for some 9-, 12-, 15-
[23], 16-[27] and 19-membered rings [30]. For the preparation of the 6-, 9-, 12- and 15- 
membered rings of type 3, the linear precursors 1 have been prepared by coupling α−hydroxy 
acids with 2H-azirin-3-amines, whereas β−hydroxy acids and 2H-azirin-3-amines led to the 
precursors of the 16- and 19-membered cyclodepsipeptides. The azirines themselves have 
been a target of our studies for some years [31-36], mainly because they proved to be useful 
synthons for α,α-disubstituted α-amino acids in peptide synthesis [31][33][34][37-40]. 
 
Because the reaction of  α−hydroxy acids with 2H-azirin-3-amines followed by the ‘direct 
amide cyclization’ proved to be a convenient access to morpholine-2,5-diones, we intended to 
generalize this reaction sequence. Therefore, we carried out the reaction under similar 
conditions with some β−hydroxy acids in order to obtain 7-membered cyclic depsipeptides. In 
the present paper, we report the results of the reaction of  2H-azirin-3-amines with 3-hydroxy-
2,2-dimethylpropanoic acid (4). 
 
2. Results and Discussion 
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2.1. Direct Amid Cyclization. - As a model β−hydroxy acid we chose 3-hydroxy-2,2-
dimethylpropanoic acid (4), mainly due to its commercial availability and its previous use in 
this type of reactions [26][27]. The linear dipeptides 6 were prepared by the standard 
procedure [26] of coupling 4 with the corresponding 2H-azirin-3-amine (5a or 5b; cf. [31] 
and refs. cit. therein), to yield 6a and 6b, respectively, in excellent yields and without side 
products (Scheme 2). 
 
Scheme 2 
 
 
 
Although the general protocol proposed MeCN as a solvent [26], THF turned out to be a 
better solvent in this particular case. In addition to the spectroscopic characterization of 6a 
and 6b (cf. [27] ), their structures were established by X-ray crystallography (Fig. 1). 
 
a) 
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b) 
 
 
Fig. 1. ORTEP-Plots [41] of the molecular structures of a) 6a  and b) one of the two 
symmetry-independent molecules of  6b (arbitrary  numbering of the atoms; 50% probability 
ellipsoids). 
 
The conformations of the backbones of 6a and 6b are very similar, with the exception of the 
orientation of the OH group. In 6a, the NH group forms an intermolecular H-bond with its 
adjacent amide O-atom from a neighboring molecule (N(4)…O(6”) 2.885(1) Å; N(4)-
H…O(6”) 161(1)o). This interaction links the molecules into extended chains which run 
parallel to the y-axis and have a graph set motif [42] of C(5). The OH group forms an 
intermolecular H-bond with its adjacent amide O-atom from a different neighboring molecule 
(O(1)…O(3’) 2.770(2) Å; O(1)-H…O(3’) 169(2)o) and thereby also links the molecules into 
infinite chains which run parallel to the y-axis and have a graph set motif of C(6). The 
combination of the intermolecular interactions links the molecules into a two-dimensional 
network which runs parallel to the xy-plane. 
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In the case of 6b, there are two symmetry-independent molecules in the asymmetric unit and 
they have almost identical conformations. The NH group in each molecule forms an 
intramolecular H-bond with the OH group (e.g. N(4)…O(7) 2.728(2) Å; N(4)-H…O(7) 142(1)o 
in molecule A) to yield a six-membered loop with a graph set motif of S(6). The OH group of 
molecule A forms an intermolecular H-bond with the primary amide O-atom of molecule B 
(O(7)‡‡‡O(25’) 2.684(1) Å; O(7)-H‡‡‡O(25’) 173(2)o), while the OH group of molecule B has a 
similar interaction with a different molecule A (O(27)‡‡‡O(5”) 2.692(1) Å; O(27)-H‡‡‡O(5”) 
174(2)o). These interactions link the molecules into infinite chains in which both symmetry-
independent molecules are incorporated in an alternating ‡‡‡A‡‡‡B‡‡‡A‡‡‡B‡‡‡ sequence. These 
chains run parallel to the y-axis and have a binary graph set motif of C 2
2
(12). 
 
The dipeptide 6b, was subjected to the reaction conditions of the ‘direct amide cycliszation’, 
i.e. dry HCl gas was bubbled through a toluene suspension of 6b at 100o.  It was expected that 
6b would react in an analogous manner to the amide 7, which gave 3,3,6,6-
tetramethylmorpholine-2,5-dione  (8) in up to 60% yield [43] (Scheme 3). Surprisingly, only 
the dimer of the expected 7-membered ring 9, namely the 14-membered 3,3,6,6,10,10,13,13-
octamethyl-1,8-dioxa-4,11-diazacyclotetradecane-2,5,9,12-tetraone (10), was formed in 72% 
yield (Scheme 3).  
 
Scheme 3 
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The 1H-NMR spectrum of 10 showed no signal for OH groups and confirmed the presence of 
NH groups. Two singlets for Me groups and a singlet for CH2 were also clearly distinguished. 
The 13C-NMR spectra showed the presence of two C=O groups (174.3 and 178.2 ppm in 
(D6)DMSO), which was further confirmed by the IR spectrum (KBr; 1723 and 1673 cm
-1). 
Furthermore, the 13C-NMR spectrum indicated two different types of Me2C groups, in 
addition to a OCH2 group. With this set of data, the distinction between the monomeric 
lactone 9 and the dimer 10 was not possible. But the mass spectra (CI and ESI mode) 
indicated a molecular weight of 370, which corresponds to the 14-membered depsipeptide 10. 
Finally its structure was confirmed by X-ray crystallography ( Fig. 2). 
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Fig. 2. ORTEP-Plot [41] of the molecular structure of 10 (arbitrary  numbering of the atoms; 
50% probability ellipsoids). 
 
The molecule sits across a crystallographic center of inversion. The symmetry-unique NH 
group forms a very weak intermolecular H-bond with the amide O-atom from the same amide 
group of an adjacent molecule (N(4)‡‡‡O(5’) 3.483(2) Å; N(4)-H‡‡‡O(5’) 170o). This 
interaction links the molecules into extended chains which run parallel to the z-axis and have 
a graph set motif of C(4). The other amide group in the molecule participates in an identical 
intermolecular interaction of necessity because of the centrosymmetric nature of the molecule. 
The chains thereby formed also run parallel to the z-axis but in the opposite direction. The 
molecules themselves bridge adjacent chains, so that the combination of both interactions 
links the molecules into two-dimensional networks which lie parallel to the (100) plane. The 
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cross-linking of the chains also builds H-bonded loops involving four molecules and yields 
the graph set motif of R 4
4
(26). 
 
With the aim of obtaining the 7-membered, monomeric cyclodepsipeptide 9 (Scheme 3), we 
repeated the reaction with varying concentrations of the starting material 6b and different 
reaction times. However, under all conditions 10 was formed as the only product, although in 
variable yield. Thus, the maximum yield of 72% was obtained at a concentration of 20 mM, 
whereas with a concentration of 2 mM the yield dropped to 35%, and at a concentration of 40 
mM the yield was only 61%. 
 
The rate determining step of the ‘direct amide cyclization’ is believed to be the formation of 
the oxazolone ring (see Scheme 1), a process favored by the precipitation of the corresponding 
ammonium salt. Thus the formation of the lactone is a function of the salt’s solubility in 
toluene2). As a result, N,N-dimethylamides of type 6a should react more easily than N-methyl-
N-phenylamides like 6b under the conditions of the ‘direct amide cyclization’, because the 
initially formed Me2NH.HCl is less soluble in toluene than Ph(Me)NH.HCl. 
 
Therefore, we also used 6a as a starting material. The cyclization with HCl gas in toluene at 
100o gave again the product 10. The lower yield (32%) is mainly caused by purification 
difficulties (see experimental part). 
 
                                                 
2) It has been shown previously, that the formation of a 16-membered cyclic depsipeptide, 
which in toluene (heterogeneous conditions) was obtained in 60% yield, does not occur in 
homogeneous solution in DMF [26]. 
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In order to prepare 10 by a specific synthesis, we synthesized the open chain precursor, the 
linear depsipeptide 11, according to standard procedures, starting from the commercially 
available methyl ester 12. After protection of the OH group by benzylation to give 13 and 
deprotection of the carboxyl group, the intermediate 14 was coupled with 5b to yield the 
diamide 15. The product of its acid-catalyzed hydrolysis 16 was coupled with 6b to give 17, 
which after deprotection gave 11 in a total yield of 24% (Scheme 4). Crystallization from a 
mixture of CH2Cl2, i-PrOH, and hexane gave crystals, which were suitable for an X-ray 
crystal-structure determination (Fig. 3). 
 
Scheme 4 
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Fig. 3. ORTEP-Plot [41] of the molecular structure of 11 (arbitrary  numbering of the atoms; 
50% probability ellipsoids). 
 
Although the molecule is achiral, the crystal structure is chiral. The absolute structure has not 
been determined and was defined arbitrarily. The amide NH group closest to the OH group 
forms an intramolecular H-bond hydroxy O-atom (N(4)…O(1) 2.709(3) Å; N(4)-H…O(1) 
135(3)o). This gives rise to a six-membered loop with a graph set motif of S(6), analogous to 
compound 6b (Fig. 1). The other amide group forms an intermolecular H-bond with the 
adjacent amide O-atom from a neighboring molecule (N(11)…O(13’’) 2.932(3) Å; N(11)-
H…O(13’’) 155(3)o). This interaction links the molecules into infinite chains which run 
parallel to the y-axis and have a graph set motif of C(5). The OH group forms an 
intermolecular H-bond with its adjacent amide O-atom from a different neighboring molecule 
(O(1)…O(3’) 2.655(3) Å; O(1)-H…O(3’) 158(4)o) and thereby also links the molecules into 
infinite chains which run parallel to the y-axis and have a graph set motif of C(6). The 
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combination of intermolecular interactions links the molecules into a two-dimensional 
network which runs parallel to the yz-plane. 
 
Compound 11 was subjected to cyclization under the standard conditions of the ‘direct amide 
cyclization’. Once more, the 14-membered cyclodepsipeptide 10 was the only product that 
could be  isolated, with the moderate yield of 42%. 
 
2.2. Other lactonisation methods. - After all attempts to obtain the 7-membered ring 9 by the 
‘direct amide cyclization’ failed, even after a ten-fold dilution of the reaction mixture, we 
were faced with a number of classical lactonisation options, starting mainly with the 
corresponding hydroxy acid 18, which was obtained easily from either of the amides 6 by 
hydrolysis in an acidic medium. The crystal-structure of 18  is shown in Fig. 4. 
 
a) 
 
b) 
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Fig. 4. ORTEP-Plots [41] of the molecular structures of a) 18 and b) one of the two symmetry-
independent molecules of 19 (arbitrary  numbering of the atoms; 50% probability ellipsoids). 
 
The NH group forms an intermolecular H-bond with the O-atom of the hydroxy group of a 
neighboring molecule (N(4)…O(7’’’) 3.086(2) Å; N(4)-H…O(7’’’) 165(2)o). This interaction 
links the molecules into extended chains which run parallel to the y-axis and have a graph set 
motif of C(6). The OH group forms an intermolecular H-bond with C=O of the COOH group 
from a different neighboring molecule (O(7)…O(2’’) 2.746(2) Å; O(7)-H…O(2’’) 170(2)o). 
This interaction also links the molecules into infinite chains which run parallel to the y-axis 
and have a graph set motif of C(9). The OH group of COOH forms an intermolecular H-bond 
with the amide O-atom of a third neighboring molecule (O(1)…O(5’) 2.606(2) Å; O(1)-
H…O(5’) 172(2)o). Again, this interaction links the molecules into infinite chains which run 
parallel to the y-axis and have a graph set motif of C(7). The combination of all H-bonding 
interactions links the molecules into two-dimensional network which lies parallel to the xy-
plane. 
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The variety of lactonization methods, is enormous, and we could try only a few of them. As 
starting point, we used the review by Nicolaou [44] where the classical methods of 
Yamaguchi [45], Corey-Nicolaou [46], and Mukaiyama [47] are mentioned. Unfortunately, 
none of the above reactions yielded the desired product, and the only products obtained were 
the activated acid derivates, namely the Yamaguchi mixed anhydride and the Corey active 
ester, respectively. Some modern variations of these methods [48] were also tried, but they 
failed to give the desired product too. The most common cyclization methods, using DCC or 
its water-soluble derivatives and analogues, gave as the only product 2-(2-hydroxy-1,1-
dimethylethyl)-4,4-dimethyloxazol-5(4H)-one (19) in 36% yield (Scheme 5). This is the 
postulated intermediate of the prospected ‘direct amide cyclization’ 69. Even after addition 
of 4-(dimethylamino)pyridine (DMAP) to a mixture of 18 and DCC, a procedure known to be 
suitable for the synthesis of  medium sized lactones [49], the reaction path did not change and 
19 was isolated as the only product, although in moderate yield.  
 
In general, 1,3-oxazol-5(4H)-ones are reactive species; in the case of 19, the gem-dimethyl 
group seems to stabilize it, so that it could be isolated in crystalline form. In the IR spectrum 
(KBr), 19 showed a characteristic strong C=O absorption at 1836 cm-1 and in the 13C-NMR 
spectrum, the singlets for C=O and C=N appeared at 182.8 and 166.6 ppm, respectively. The 
structure of 19 was established by X-ray crystallography (Fig. 4). 
 
Scheme 5 
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The asymmetric unit contains two symmetry-independent molecules, whose conformations 
differ only in the orientation of the OH group. The OH group of molecule A forms an 
intermolecular H-bond with the N-atom of molecule B (O(7)…N(21’) 2.891(2) Å; O(7)-
H…N(21’) 159(3)o). In turn, molecule B has an identical interaction with another molecule A. 
These interactions link the molecules into extended  ‡‡‡A‡‡‡B‡‡‡A‡‡‡B‡‡‡ chains which run 
parallel to the y-axis and have a graph set motif [42] of C 2
2
(12). 
As 19 is expected to be the intermediate in the ‘direct amide cyclization’ 69, we attempted 
to transform 19 to the depsipeptide in polar, aprotic solvents (AcOEt, MeCN), but all attempts 
failed. After two days of heating 19 under reflux, only the starting material was isolated. 
Another way of converting 19  to  the depsipeptide  9 was the ‘direct amide cyclization’. This 
reaction yielded again only product 10 in excellent yield (86%, Scheme 6). 
 
Scheme 6 
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The next step we took on the way to the synthesis of the 7-membered 9 was to try out some 
reactions involving salts of metals, such as Sb [50], Sn [51], Ag [52], Sc [53] and Ru [54], 
known to catalyze the formation of small and medium sized lactones. Most of these attempts 
failed in the case of 18, and only few led to a definite product, namely once more the dimeric 
cyclodepsipeptide  10 (Scheme 6). Surprisingly, the reaction with I2 in boiling MeCN, which 
was initially used to cyclize terpene-like hydroxy acids [55], gave again the 14-membered 
ring 10 in moderate yield (Scheme 6). Recently, Richard et al. have reported the synthesis of 
7-membered lactones, containing an amino group in their basic structure, by treatment of the 
corresponding hydroxy esters with NaH in a toluene suspension [56]. Therefore, we treated 
the ester 20 under the same conditions. To our disappointment, this reaction yielded again the 
dimeric compound 10 as the sole product. 
 
The discrepancy between the reactions of 6-hydroxy-4-azahexanoic esters [56] and 6 is very 
surprising. One of the possible reasons for the failure of this method in the case of 6 could lie 
in the presence of the amide bond and its rigidity. With the aim of proving this hypothesis, the 
ester analogue of the amide 6, i.e. the diester 22, was synthesized in the same way as 
compound 11 (Scheme 7). 
 
Scheme 7 
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Subjecting compound 22 to the reaction conditions described in [56] led to a mixture of 
products, among which the tri- and tetralactones 23 and 24 were isolated as the main 
products. None of the expected 7-membered dilactone could be detected. As an additional 
product, 2-hydroxyisobutyric acid  was also obtained. The structures of 23 and 24, i.e. the 
cyclic tri- and tetramers of 3-hydroxy-2,2-dimethylpropanoic acid (4) were confirmed by X-
ray crystal-structure analyses (Fig. 5). It turned out that these compound are already known, 
and the crystal-structure of 24 has been published previously [57]. They have been prepared 
by oligomerisation of 3-hydroxy-2,2-dimethylpropionolactone 25. Therefore, we propose that 
in the reaction of 22 with NaH, 25 is formed by the intramolecular nucleophilic attack of the 
OH group at the central ester group and cleavage of this ester. Then, 25 undergoes the 
oligomerisation. Apparently, the alternative nucleophilic attack at the terminal ester group of 
22, which would lead to the 7-membered dilactone, cannot compete with the formation of the 
β-lactone. 
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a)                                                                  b) 
      
 
 
Fig. 5. ORTEP-Plots [41] of the molecular structures of  a) one of the two symmetry-
independent molecules of 23 and b) 24 (arbitrary  numbering of the atoms; 50% probability 
ellipsoids). 
 
3. Conclusions 
 
In conclusion, our attempts to prepare the 7-membered cyclic depsipeptide 3,3,6,6-
tetramethyl-1-oxa-4-azacycloheptane-2,5-dione (9) using the ‘direct amide cyclization’ 
starting with 3-hydroxy-2,2-dimethyl-N-[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]-
propanamide (6b) failed. The only product obtained was the dimeric  14-membered 
cyclodepsipeptide 10, which was formed in a very good yield. Furthermore, the attempts to 
prepare the monomeric lactone 9 using various classical lactonisation procedures failed too, 
and in almost all cases 10 was obtained as the main product in yields of 28-72%. Five 
different methods for the synthesis of 10 were developed. Despite all the variations in reaction 
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conditions and the knowledge of the crystal structures of the starting materials and some of 
the intermediates, there is no convincing explanation for this unexpected result and additional 
experiments are required. 
 
We thank the analytical units of our institute for spectra and analysis, and the  Swiss National 
Science Fondation and F. Hoffmann-La Roche AG, Basel, for financial support. 
 
Experimental Part 
 
1. General. Thin-layer chromatography (TLC): Merck TLC aluminium sheets, silica gel 60 
F254. Prep. TLC: Merck PLC plates (glass), silica gel 60 F254, 2 mm and 40-63 µm. Flash 
chromatography (CC): Uetikon-Chemie ‘Chromatographiegel’ C-560. M.p.: Büchi 540 
apparatus, uncorrected. IR Spectra: Perkin-Elmer Spectrum one spectrometer; in KBr,  unless 
otherwise stated, absorption bands in cm-1. 1H-NMR (300 MHz) and 13C-NMR (75.5 MHz) 
spectra: Bruker ARX-300 instrument; in CDCl3  at 300 K; TMS as internal standard, unless 
otherwise stated; δ in ppm, coupling constants J in Hz. HSQC and HMBC spectra: Bruker 
DRX-600 instrument; 1H-NMR (600 MHz) and 13C-NMR (150 MHz). Mass spectrometry 
(MS): Finnigan MAT-90 for electron impact ionization (EI), Finnigan SSQ-700 for chemical 
ionization (CI, with NH3) and electrospray ionization (ESI, in MeOH + Na), unless otherwise 
stated. 
2.  Starting materials. 2,2,N,N-Tetramethyl-N-phenyl-2H-azirin-3-amine (5a) and 2,2,N-
trimethyl-N-phenyl-2H-azirin-3-amine (5b) were prepared according to standard procedures 
(cf. [31] and refs. cited therein). All other products used were commercially available. 
 
3. Coupling with 2H-Azirin-3-amines. 
 21 
N-[1-(Dimethylcarbamoyl)-1-methylethyl]-3-hydroxy-2,2-dimethylpropanamide (6a). To a 
soln. of 3-hydroxy-2,2-dimethylpropanoic acid (4; 806 mg, 6.84 mmol) in dry THF (5ml), 5a 
(1.231 g, 7.52 mmol) was added dropwise. The mixture was stirred at r.t. for 36 h, the solvent 
was evaporated, and the remaining solid was purified by CC (SiO2, MeOH/CH2Cl2 1:10) and 
dried in h.v. Yield: 1.200 g (76%) of 6a. Pale yellow  crystals. M.p. 126.2-127.4o. 1H-NMR: 
1.10, 1.33 (2s, 2 Me2C); 3.22 (s, Me2N); 3.46 (s, CH2O); 3.90 (br. s,  OH); 6.79 (br. s,  NH). 
13C-NMR: 22.1, 26.3 (2q, 2 Me2C); 41.6 (s, Me2C); 42.4 (q, Me2N); 58.7 (s, Me2C);  70.4 (t, 
CH2O);  174.1, 177.2 (2s, 2 CO). CI-MS: 231 (68, [M + 1]
+), 186 (100). 
 
3-Hydroxy-2,2-dimethyl-N-[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]propanamide 
(6b). To a soln. of 4 (806 mg, 6.84 mmol) in dry THF (5ml), 5b (1.309 g, 7.52 mmol) was 
added dropwise. The mixture was stirred at r.t. for 24 h, the solvent was evaporated and the 
remaining solid was purified by CC (SiO2, MeOH/CH2Cl2 1:20) and dried in h.v. Yield: 1.86 
g (93%) of 6b. White solid. M.p.102.8-103.3o ([27]: 103.4-104o). 1H-NMR: 1.11, 1.38 (2s, 2 
Me2C); 3.28 (s, MeN); 3.44 (s, CH2O); 3.90 (br. s,  OH); 6.77 (br. s, NH); 7.25-7.45 (m, 5 
arom. H). 13C-NMR: 22.2, 26.3 (2q, 2 Me2C); 41.6 (s, Me2C); 43.6 (q, MeN); 58.7 (s, Me2C); 
70.4 (t, CH2O); 128.2 (d, 1 arom. CH); 128.4, 129.5 (2d, 4 arom. CH); 144.4 (s, 1 arom. C); 
174.1, 177.2 (2s, 2 CO). 
 
4. Cyclizations to 3,3,6,6,10,10,13,13-Octamethyl-1,8-dioxa-4,11-diazacyclotetradecane-
2,5,9,12-tetraone (10). 
4.1. Direct Amide Cyclisations. Procedure A. A suspension of 6b (584 mg, 2 mmol) in  dry 
toluene (100 ml) was heated to 100o, and HCl gas was bubbled through the suspension for 7 
min. Then, the mixture was let to cool to r.t. while bubbling N2 through it (ca. 20 min). The 
solvent was evaporated, the white residue was washed with 3 × 15 ml of CH2Cl2 and dried in 
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h.v. Yield: 267 mg (72%) of 10. White powder. M.p. 299.2-300.4o. IR: 3393vs (NH), 2990s, 
2977s, 2935m, 1723vs (C=O), 1673vs (C=O), 1523vs, 1171vs (C-O). 1H-NMR ((D7)DMF): 
1.12, 1.40 (2s, 2 Me2C each ); 4.00 (s, 2 CH2O); 7.64 (s, 2 NH). 
13C-NMR ((D7)DMF): 22.1, 
24.6 (2q, 2 Me2C each); 41.6, 55.4 (2s, 2 Me2C);  71.3 (t, CH2O);  174.3 (s, C=O). 
13C-NMR 
((D6)DMSO): 20.9, 23.2 (2q, 2 Me2C each); 40.4, 54.4 (2s, 2 Me2C);  70.1 (t, CH2O);  173.0, 
174.3 (s, C=O). CI-MS: 388 (34, [M + NH4]
+), 371 (100, [M + 1]+). ESI-MS: 393 (100, [M + 
Na]+). Anal. calc. for C18H30N2O6 (370.45): C 58.36, H 8.16, N 7.56; found C 57.94, H 8.18, 
N 7.47. 
Procedure B. A suspension of 6a (230 mg, 1 mmol) in  dry toluene (50 ml) was heated to 
100o, and HCl gas was bubbled through the suspension for 3 min. Then, the mixture was let to 
cool to r.t. while bubbling N2 through it (ca.20 min). The solvent was evaporated, the white 
residue was washed with 3 × 10 ml of CH2Cl2 and the remaining solid was recrystallized from 
MeCN to yield  60 mg (32%) of 10. 
Procedure C. A suspension of 11 (see section 5, 477 mg, 1 mmol) in  dry toluene (50 ml) was 
heated to 100o, and HCl gas was bubbled through the suspension for 3 min. Workup as 
described in Procedure A gave 92 mg (49%) of 10. 
 
 23 
4.2 Other lactonisation methods. 2-[(3-Hydroxy-2,2-dimethyl-propanoyl)amino]-2-methyl-
propanoic acid (18). To a soln. of  6b (2.00 g, 7.35 mmol) in  THF (10 ml), 3N HCl (10 ml) 
was added dropwise at  0o  under constant stirring. After 8 h at r.t., THF was removed i.v. and 
the H2O phase was extracted with  AcOEt (5 × 20 ml). The combined org. fractions were 
dried (MgSO4) and the solvent evaporated. The remaining brownish  crystals were washed 
twice with Et2O/PrOH 100:1. Yield: 1.312g (92%) of 18. White crystals. M.p.142.3-143.4
o 
([27]: 142.8-144.0o). 1H-NMR ((D6)DMSO): 1.00, 1.35 (2s, 2 Me2C); 3.36 (s, CH2O); 5.00 
(br. s, OH); 7.52 (br. s, NH); 12.12 (br. s, COOH). 
Procedure D. A soln. of 18 (205 mg, 1 mmol) and I2  (15 mg, 0.06 mmol)  in dry MeCN (15 
ml) was heated to reflux for 3 d. After evaporation of the solvent, the residue was washed 
with  5% Na2S2O3 soln. and extracted with AcOEt, and the combined org. fractions were 
dried (MgSO4). Purification by CC yielded 89 mg (49%) of 10 as a white powder. 
Procedure E. A soln. of 18 (103 mg, 0.5 mmol) and Bu2SnO (25 mg, 0.1 mmol)  in dry 
xylene (25 ml) was heated under reflux for 2 d in a  Dean-Stark apparatus (N2 -atmosphere). 
Then, the solvent was evaporated i.v., the solid residue was washed with Et2O (2 × 10 ml) and 
than with warm acetone (5 × 10 ml). The acetone fraction was concentrated to 5 ml, cooled  
and filtered to yield 36 mg (38%) of 10. 
Ethyl 2-[(3-Hydroxy-2,2-dimethylpropanoyl)amino]-2-methylpropanoate (20). A soln. of 6b 
(584 mg, 2 mmol) in a 10% EtOH soln. in toluene (110 ml) was heated to 100o, and HCl gas 
was bubbled through the suspension for 7 min. Then, the mixture was let to cool to r.t. while 
bubbling N2 through it (ca. 20 min). The solvent was evaporated, purification by CC 
(CH2Cl2/acetone 100:1) yielded  397 mg (86%) of 20 as colorless oil. 
1H-NMR: 1.14 (s, Me2C 
); 1.28 (t, MeCH2O); 1.43 (s, Me2C ); 3.53 (d, CH2OH); 4.05 (q, MeCH2O); 6.79 (s, NH). 
13C-
NMR: 15.6 (q, Me); 22.1, 26.3 (2q, 2 Me2C); 41.6 (s, Me2C);  61.4 (t, CH2O); 69.1 (t, CH2O); 
76.8 (s, Me2C); 174.3, 178.6 (2s, 2 CO). ESI-MS: 254 (100, [M + Na]
+). 
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Procedure F. To a soln. of 20 (232 mg, 1 mmol)  in dry toluene (5 ml), NaH (40 mg of a 60% 
suspension in mineral oil, 1 mmol) was added slowly at 0o and under constant stirring (N2 -
atmosphere). After 4.5 h at 80o, the mixture was acidified with 0.1 N HCl (~6 ml) to pH 5 and 
extracted with CH2Cl2 and AcOEt. The combined org. fractions were dried (MgSO4) and 
evaporated i.v. The crystalline residue was washed with  CH2Cl2 to yield 52 mg (28%) of 10. 
 
5. Synthesis of 2-Methyl-2-{[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]-
carbamoyl}propyl 2-[(3-Hydroxy-2,2-dimethyl-propanoyl)amino]-2-methylpropanoate (11). 
Methyl 3-Benzyloxy-2,2-dimethylpropanoate (13). To a suspension of  NaH (440 mg of a 60% 
suspension in mineral oil, 11 mmol) in dry THF (15 ml)  methyl 3-hydroxy-2,2-
dimethylpropanoate (1.322 g, 10 mmol) was added dropwise at 0o  and under constant 
stirring. The reaction was stirred at r.t. for 1 h, then benzyl bromide (1.710 g, 10 mmol) was 
added. After heating under reflux for 3 h, the mixture was cooled, washed with brine (2 × 
25ml ), the brine fractions were extracted with AcOEt and the combined org. fractions were 
dried (MgSO4). Purification by CC (SiO2 , hexane/Et2O 10:1) yielded 1.05 g (47%) of 13. 
Colorless oil. IR (film):  2976m, 2863m, 1736vs (C=O), 1475s, 1454s, 1363m, 1308s, 1226s, 
1192s, 1152s (C-O), 1100s (C-O), 1029m, 738m, 698m. 1H-NMR: 1.37 (s, Me2C); 3.62 (s, 
CH2O); 3.84 (s, MeO); 4.68 (s, PhCH2); 7.40-7.52 (m, 5 arom. H). 
13C-NMR: 22.4 (q, Me2C); 
43.6 (t, CH2); 51.7 (s, Me2C); 73.1 (q, MeO); 76.9 (t, PhCH2); 127.3, 127.6, 128.2 (3d, 5 
arom. CH); 138.4 (s, 1 arom. C); 176.8 (s, C=O). EI-MS: 222 (28, M+·), 116 (26), 107 (20), 
101 (20), 91 (100), 65 (8).  
3-Benzyloxy-2,2-dimethylpropanoic acid (14). To a soln. of of 13 (1.00 g, 4.5 mmol) in EtOH 
(20 ml), 8 ml of 2N KOH were added  at 0o . After 1 h stirring at r.t., the org. solvent was 
evaporated i.v., the remaining soln. was  acidified with 1N HCl to pH 1 and extracted with 
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Et2O. The org. fractions were dried (MgSO4) and evaporated i.v. The residue was 
recrystallized from hexane. Yield: 830 mg (88%) of 14. White crystals. M.p. 62.1-63.8o. IR:  
2975m, 2861m, 1707vs (C=O), 1454s, 1364m, 1163w, 1100s (C-O), 738m, 698m. 1H-NMR 
((D6)DMSO): 1.07 (s, Me2C); 3.42 (s, CH2O); 4.49 (s, PhCH2); 7.25-7.42 (m, 5 arom. H); 
12.21 (s, COOH). 13C-NMR ((D6)DMSO): 22.2 (q, Me2C); 40.6 (s, Me2C); 72.3 (t, CH2O); 
76.7 (PhCH2); 127.2, 127.3, 128.1 (3d, 5 arom. CH);  138.4 (s, 1 arom. C); 177.3 (s, COOH).  
EI-MS: 208 (7, M+·), 107 (49), 91 (100), 79 (9), 65 (9). 
3-Benzyloxy-2,2-dimethyl-N-[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]propanamide 
(15). To a soln. of 14 (800 mg, 3.85 mmol)  in  THF (10 ml), a soln. of  5b (670 mg, 3.85 
mmol) in THF (2 ml) was added dropwise. After 24 h, the solvent was removed i.v. and the 
residue was purified by CC (CH2Cl2/MeOH 40:1). Yield: 1.230 g (84%) of 15. White solid. 
M.p.105.6-106.8o. IR: 3339vs (NH), 2992m, 2956m, 2838m, 1644vs (C=O), 1593m, 1253s, 
1103s (C-O), 976w, 753m, 713m, 618w. 1H-NMR: 0.98, 1.31 (2s, 2 Me2C); 3.08 (s, CH2O); 
3.14 (s, MeN); 4.31 (s, PhCH2); 6.96 (s, NH), 7.12-7.27 (m, 10 arom. H). 
13C-NMR: 22.8, 
26.4 (2q, 2 Me2C); 41.2 (q, MeN); 42.5, 57.4 (2s, 2 Me2C); 73.3 (t, CH2O); 76.4 (t, PhCH2); 
127.4, 127.5, 127.7, 127.9, 128.3, 129.1 (6d, 10 arom. CH); 137.6, 145.1 (2s,  2 arom. C); 
173.2, 175.2 (2s, 2 C=O). ESI-MS:  405 (100, [M + Na]+). 
2-[(3-Benzyloxy-2,2-dimethylpropanoyl)amino]-2-methylpropanoic acid  (16). To a soln. of 
15 (1.200 g 3.14 mmol) in THF (5 ml), 3N HCl (5 ml) was added dropwise at 0o. The mixture 
was left overnight at r.t., the org. solvent was evaporated i.v., and the residue was extracted 
with AcOEt. The combined org. fractions were washed with brine and dried (MgSO4). After 
evaporation, the crystals were washed with Et2O/hexane 2:1. Yield: 818 mg (89%). White 
crystals. M.p.109.4-110.2o. IR:  3355vs (OH), 2989-2863s (br.), 1717vs (C=O), 1620vs 
(C=O), 1533vs, 1468s, 1397s, 1257s, 1162s, 1162s, 1092vs, 1012m, 930m, 8289s, 753s, 
704m, 693m. 1H-NMR: 1.17, 1.46 (2s, 2 Me2C); 3.44 (s, CH2O); 4.56 (s, PhCH2); 7.31-7.39 
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(m, 5 arom. H, NH). 13C-NMR:  22.8, 24.8 (2q, 2 Me2C); 42.5, 56.6 (2s, 2 Me2C); 73.6 (t, 
CH2O); 76.4 (t, PhCH2); 127.6, 127.9, 128.4 (3d, 5 arom. CH); 137.2 (s, 1 arom. C); 177.2, 
178.0 (2s, 2 C=O). CI-MS: 294 (100, [M + 1]+), 295(18). 
2-Methyl-2-{[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]carbamoyl}propyl 2-[(3-
Benzyloxy-2,2-dimethylpropanoyl)amino]-2-methylpropanoate (17). To a soln. of  16 (1.00 g, 
3.41 mmol) in dry THF (15 ml), 1,1’-carbonyldiimidazol (CDI; 552 mg, 3.41 mmol) was 
added. After 2 h  stirring at r.t.,  6b  (934 mg, 3.41 mmol) was added, followed by the 
dropwise addition of a Na-imidazolid suspension (73 mg imidazol, 45 mg of a 60% NaH 
suspension in mineral oil and 3 ml of THF). After stirring overnight, the org. solvent was 
removed i.v. and the residue was purified by CC (CH2Cl2/acetone 60:1). Yield: 1.276g (66%) 
of 17. White solid. M.p. 114.2-115.8o. IR: 3353s (NH), 2980m, 2934m, 2873m, 1739vs 
(C=O), 1702m, 1664vs (br., C=O), 1594s, 1520s, 1494m, 1454m, 1385m, 1382m, 1150vs (C-
O), 1091m, 1023m, 923m, 904m, 738m, 705m. 1H-NMR: 1.13, 1.14 (2s, 2 Me2C); 1.44 (s, 2 
Me2C); 3.27 (s, MeN); 3.42 (s, CH2OH); 4.03 (s, CH2O); 4.57 (s,  PhCH2); 7.04 (s, NH); 7.21-
7.41 (m, 10 arom. H, NH). 13C-NMR: 22.3,  22.9, 24.7, 25.2 (4q, 4 Me2C); 41.4 (q, MeN); 
42.5, 42.7, 55.8, 58.3 (4s, 4 Me2C);  70.9 (t, CH2O); 73.5 (t, CH2O); 76.6 (PhCH2); 127.5, 
127.7, 128.0, 128.3, 128.3, 129.3 (6d, 10 arom. H); 137.6,  144.3 (2s, 2 arom. C); 173.6, 
173.7, 174.0, 175.8 (4s, 4 C=O). CI-MS: 590 (100, [M + Na]+). 
 2-Methyl-2-{[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethy]lcarbamoyl}propyl 2-[(3-
Hydroxy-2,2-dimethylpropanoyl)amino]-2-methylpropanoate (11). To a soln. of 17  (1.200 g, 
2.11 mmol)  in dry CH2Cl2 (15 ml), 150 mg of Pd/C were added and the mixture was stirred 
under an H2 -atmosphere at r.t. overnight. The suspension was filtered over celite, and 
evaporated i.v. The product was used without further purification. Yield: 901mg (89%) of 11. 
White crystals. M.p. 139.2-140.3o. IR: 3358vs (OH), 3281m, 2981m, 2886m, 1746vs (C=O), 
1664vs, 1623vs, 1592s, 1533vs, 1382s, 1264s, 1224m, 1144vs, 1140m, 1062m, 1024w, 781m, 
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708s. 1H-NMR ((D6)DMSO): 0.99, 1.04, 1.31, 1.38 (4s, 4 Me2C); 3.20 (s, MeN); 3.34 (d, 
3J = 
6, CH2O); 3.91 (s, CH2O);  4.97 (t, 
3J = 6, OH); 7.16-7.28 (m, 2 arom. H, NH); 7.30-7.40 (m, 
3 arom. H); 7.58 (s, NH). 13C-NMR ((D6)DMSO): 21.9, 22.1, 24.6, 25.9 (4q, 4 Me2C); 41.6, 
42.6, 54.8, 56.4 (4s, 4 Me2C); 67.5, 69.9 (2t, 2 CH2O); 126.3, 127.0, 128.7 (3d, 5 arom. CH); 
137.8 (s, 1 arom. C); 172.3, 173.6, 173.7, 175.61 (4s, 4 C=O). ESI-MS: 500 (100, [M + Na]+). 
 
6. Formation of 2-(2-Hydroxy-1,1-dimethylethyl)-4,4-dimethyloxazol-5(4H)-one (19). 
Procedure F. A soln. of 18 (103 mg, 0.5 mmol)  and N,N’-dicyclohexylcarbodiimide (DCC; 
104 mg, 0.5 mmol) in AcOEt (10 ml) was stirred overnight at r.t., then filtered, washed with 
AcOEt, and the solvent was evaporated i.v. Recrystallisation of the residue from MeCN 
yielded 33mg (36%) of  19 as white crystals. M.p. 128.1-128.8o. IR:  3327vs (OH), 2928vs, 
2850vs, 1836vs, 1626vs, 1574vs, 1536vs, 1436m, 1311s, 1271m, 1243s, 1088s, 1045m, 892m, 
641s. 1H-NMR ((D6)DMSO): 1.13, 1.30 (2s, 2 Me2C); 3.41 (d, 
3J = 6, CH2OH); 4.91 (t, 
3J = 6, 
OH). 13C-NMR ((D6)DMSO): 21.3, 24.2 (2q, 2 Me2C); 64.9, 67.4 (2s, 2 Me2C); 166.6 (s, 
C=N); 181.8 (s, C=O). CI-MS: 204 (100, [M + NH4]
+), 186 (30, [M + 1]+), 174 (10), 158 (6). 
Procedure G. A soln. of 18 (103 mg, 0.5 mmol)  and  1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (86 mg, 0.5 mmol) in AcOEt (10 ml) was stirred overnight 
at r.t., then  washed with brine and extracted with AcOEt. The combined org. fractions were 
dried (MgSO4), the solvent was evaporated i.v., and the residue purified by CC 
(CH2Cl2/acetone 150:1). Yield: 26mg (28%) of 19. 
Procedure H. A soln. of 18 (103 mg, 0.5 mmol)  and  4-(dimethylamino)pyridine (DMAP; 66 
mg, 0.5 mmol) in CH2Cl2 (10 ml) was stirred for 15 min at  r.t. Then, DCC (103 mg, 0.5 
mmol) was added. The mixture was left overnight, then filtered, washed with AcOEt, and the 
solvent was evaporated i.v. Purification  by CC (CH2Cl2/acetone 150:1) yielded 42 mg (45%) 
of 19. 
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7. Synthesis and Cyclization of 1-Ethoxycarbonyl-1-methylethyl 3-Hydroxy-2,2-
dimetylpropanoate. 
1-Ethoxycarbonyl-1-methylethyl 3-Benzyloxy-2,2-dimethylpropanoate (21). To a soln. of 14 
(1.00 g, 3.41 mmol) in dry THF (15 ml), CDI (552 mg, 3.41 mmol) was added and the 
mixture was stirred at r.t. for 2 h. Then, methyl 2-hydroxy-2,2-dimethylethanoate (450 mg, 
3.41 mmol) was added followed by the dropwise addition of 3 ml of  a Na-imidazolid 
suspension (73 mg imidazole, 45 mg of a 60% NaH suspension in mineral oil and 3 ml THF). 
After stirring overnight, the org. solvent was removed i.v. and the residue purified by CC 
(CH2Cl2/acetone 100:1). Yield: 780 mg (48%) of 21. Colorless oil. IR (film): 2983m, 1743vs 
(C=O), 1471w, 1383w, 1293m, 1179s (C-O), 1130s (C-O), 1028m, 738w, 698w. 1H-NMR: 
1.21 (s + t,  Me2C, MeCH2O); 1.52 (s, Me2C); 3.47 (s,  CH2O);  3.76 (q,  MeCH2O); 4.52 (s, 
PhCH2); 7.25-7.32 (m, 5 arom. H). 
13C-NMR: 13.9 (q, Me); 22.2, 24.3 (2q, 2 Me2C); 43.4 (s, 
Me2C ); 60.9 (t, MeCH2O); 73.2 (t, CH2O); 76.7 (t, PhCH2); 77.9 (s, Me2C); 127.2, 127.3,  
128.1 (3d, 5 arom. CH); 138.5 (s, 1 arom. CH); 172.5, 175.1 (2s, 2 C=O). ESI-MS: 345 (100, 
[M + Na]+). 
1-Ethoxycarbonyl-1-methylethyl 3-Hydroxy-2,2-dimethylpropanoate (22). To a soln. of 19  
(900 mg, 2.61 mmol)  in dry CH2Cl2 (15 ml), 120 mg of Pd/C were added and the mixture 
was stirred under H2-atmosphere at r.t.  overnight. The suspension was filtered over celite, 
and evaporated i.v. The product was used without further purification. Yield: 777 mg (91%) 
of 22. Colorless oil. IR (film): 3528w (br.), 2885m, 2939m, 1743vs (C=O), 1474m, 1296s, 
1180m (C-O), 1128s (C-O), 1053m, 882w, 758w, 670w. 1H-NMR: 1.11 (s, Me2C ); 1.22 (t, 
MeCH2O); 1.53 (2s, 2 Me2C ); 3.53 (d, CH2OH); 4.13 (q, MeCH2O).  
13C-NMR: 13.8 (q, Me); 
21.5, 24.4 (2q, 2 Me2C); 44.3 (s, Me2C); 61.3 (t, MeCH2O); 70.0 (t, CH2O); 78.5 (s, Me2C); 
172.6, 176.1 (2s, 2 C=O). ESI-MS: 255 (100, [M + Na]+). 
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3,3,7,7,11,11-Hexamethyl-1,5,9-trioxacyclododecane-2,6,10-trione (23) and 
3,3,7,7,11,11,15,15-Octamethyl-1,5,9,13-tetraoxacyclohexadecane-2,6,10,14-tetraone (24). 
To a soln. of 22  (232 mg, 1 mmol)  in dry toluene (5 ml), NaH (40 mg of a 60% suspension 
in mineral oil, 1 mmol) was added slowly at 0o and under constant stirring (N2 -atmosphere). 
After 5 h at 80o, the mixture was acidified with 0.1 N HCl (~6 ml) to pH 5 and extracted with 
CH2Cl2 . The combined org. fractions were dried (MgSO4) and evaporated i.v. The crystalline 
residue was purified by CC (CH2Cl2/acetone 200:1) to yield  24 mg  (8%) of 23. M.p. [57]and  
38 mg (9.5%) of 24[57]. 
 
8. X-ray Crystal-Structure Determination of 6a, 6b, 10, 11, 18, 19, and  23 (Table and Figs. 
1-5)3). All measurements were made on a Nonius KappaCCD diffractometer [58] using 
graphite-monochromated MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems 
Cryostream 700 cooler. The data collection and refinement parameters are given in the Table 
and views of the molecules are shown in Figs. 1-5. Data reductions were performed with HKL 
Denzo and Scalepack [59]. The intensities were corrected for  Lorenz and polarization effects, 
but not for absorption. The structures were solved by direct methods using SIR92 [60], which 
revealed the positions of all non-H atoms. There were two symmetry-independent molecules 
in the asymmetric unit of 6b, 19 and 23. In each case the atomic coordinates of the two 
molecules were tested carefully for a relationship from a higher symmetry space group using 
the program PLATON [61], but none could be found. The non-hydrogen atoms were refined 
anisotropically.  Except for 10, the amide and hydroxy H-atoms in the structures were placed 
                                                 
3) CCDC- 210670-210676 contain supplementary crystallographic data for this paper. These 
data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or form 
the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB12 1EZ, U.K. 
(fax : +44-(0)1223-336033; e-mail: deposit@ccdc.cam.ac.uk)) 
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in the positions indicated by difference electron density maps and their positions were 
allowed to refine together with individual isotropic displacement parameters. All remaining 
H-atoms in all structures were placed in geometrically calculated positions and each was 
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its parent 
atom (1.5Ueq for the Me groups of 6a, 11, 19 and 23).  For 6b, 10 and 18, each structure was 
refined on F using full-matrix least-squares procedures, which minimized the function Σw(|Fo| 
– |Fc|)
2. Refinement of the remaining structures was carried out on F2 by minimizing the 
corresponding function based on F2. Corrections for secondary extinction were applied with 
the exception of 18. In 6b, 10, 11, 18 and 23, six, two, one, three and three reflections, 
respectively, were omitted from the final refinement of each structure because their observed 
intensities were much lower than the calculated values as a result of being partially obscured 
by the beam stop. Neutral atom scattering factors for non-H atoms were taken form [62a] and 
the scattering factors for H-atoms were taken from [63]. Anomalous dispersion effects were 
included in Fc [64]; the values for f' and f'' were those of [62b]. The values of the mass 
attenuation coefficients are those of [62c]. All calculations were performed using the teXsan 
crystallographic software package [65] for 6b, 10, and 18 and the SHELXL97 program [66] 
for 6a, 11, 19, and 23, respectively. 
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